MedTrace Logo

The GRADE Capillary Blood Collection Pilot Study

NCT02388100 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 70

Last updated 2024-11-15

No results posted yet for this study

Summary

This pilot study is planned to validate the comparability of HbA1c results obtained from whole blood collection via venous phlebotomy versus a capillary collection of whole blood. The participant will self-collect capillary blood into HbA1c prep vials containing a buffer; these prep vials will be sent to the CBL at ambient temperature via US Postal System (USPS) mail. The feasibility of self-collection of these capillary samples by GRADE participants will also be evaluated.

Conditions

Interventions

PROCEDURE

Capillary HbA1c collection

Sponsors & Collaborators

  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

    collaborator NIH

  • GRADE Study Group

    lead OTHER

Principal Investigators

  • David Nathan, MD · Massachusetts General Hospital

Eligibility

Min Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-03-31
Primary Completion
2016-08-31
Completion
2016-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02388100 on ClinicalTrials.gov